VNV Global AB (publ) - 30 Dec 2022 Form 3 Insider Report for Babylon Holdings Ltd (BBLN)

Role: 10%+ Owner
Signature: /s/ Per Brilioth, Managing Director for VNV Global AB (publ)
Issuer symbol: BBLN
Transactions as of: 30 Dec 2022
Net transactions value: $0
Form type: 3
Filing time: 30 Dec 2022, 15:01:25 UTC
Next filing: 22 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BBLN	Class A ordinary shares						3,324,819	30 Dec 2022	See footnote	F1
holding	BBLN	Class A ordinary shares						709,812	30 Dec 2022	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These Class A ordinary shares (the "Shares") are owned directly by VNV (Cyprus) Limited ("VNV Cyprus"). VNV Cyprus is a wholly-owned subsidiary of VNV Global AB (publ) ("VNV Global"). VNV Global may be deemed to beneficially own the Shares held by VNV Cyprus.
F2	These Shares are owned directly by Global Health Equity (Cyprus) Ltd ("Global Health Equity"). VNV Global indirectly holds, through its direct wholly-owned subsidiary, VNV Sweden AB ("VNV Sweden"), approximately 37.3521% of the shares in Global Health Equity AB (publ) ("Global Health (publ)"), the direct and sole shareholder of Global Health Equity, with the remainder held by other foreign institutional investors and individuals. VNV Global may be deemed to beneficially own the Shares held by Global Health Equity.

Content

These Class A ordinary shares (the "Shares") are owned directly by VNV (Cyprus) Limited ("VNV Cyprus"). VNV Cyprus is a wholly-owned subsidiary of VNV Global AB (publ) ("VNV Global"). VNV Global may be deemed to beneficially own the Shares held by VNV Cyprus.

These Shares are owned directly by Global Health Equity (Cyprus) Ltd ("Global Health Equity"). VNV Global indirectly holds, through its direct wholly-owned subsidiary, VNV Sweden AB ("VNV Sweden"), approximately 37.3521% of the shares in Global Health Equity AB (publ) ("Global Health (publ)"), the direct and sole shareholder of Global Health Equity, with the remainder held by other foreign institutional investors and individuals. VNV Global may be deemed to beneficially own the Shares held by Global Health Equity.